None listed
Conditions
Interventions
Intervention1: Stable isotopically labelled vitamin B12 and sodium propionate: Stable isotopically labelled 13C-vitamin B12 and 13C-sodium propionate
Control Intervention1: Nil: Nil
Sponsors
Department of Biotechnology
Eligibility
Inclusion criteria
Inclusion criteria: Healthy adults male of BMI <25kg/m2 will be included in the study.
Exclusion criteria
Exclusion criteria: Individuals who are diagnosed; 1) Anemia 2) Use of drug that would interfere with B12 absorption 3) Unrecognized B12 malabsorption 4) Evidence of chronic infections such as HIV, VDRL, Hepatitis surface antigen (HBsAg).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To develop a state of art stable isotope labeled vitamin B12 absorption method that mimics the radioactive Schillings test to accurately estimate the absorption of vitamin B12. To define a method for measuring B12 flux through the propionate metabolism pathway that is regulated by vitamin B12, as an in vivo method to functionally measure vitamin B12 deficiency. Timepoint: One day measurement for each of the study outcome. | — |
Secondary
| Measure | Time frame |
|---|---|
| Validation of vitamin B12 absorption measurements against active B12 (holo-transcobalamin).Timepoint: One day measurement. | — |
Countries
India
Contacts
Public ContactSarita
St. Johns Medical College
Outcome results
None listed